Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that Board of Directors of the Company at its Meeting held ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jaysynth Orgochem's board met on 12th November 2025 and approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025, along with the Limited Review Report from statutory auditor M/s. A H J & Associates. The board also approved the Statement of Assets and Liabilities and Cash Flow Statement for H1 FY26. The meeting ran from 12:00 noon to 2:00 pm. No specific financial figures are disclosed in this filing — only the agenda items are listed.
This is a routine procedural filing confirming that quarterly results have been approved. Investors should look at the actual results document for revenue, profit, and margin details to gauge the company's performance.